Related references
Note: Only part of the references are listed.Genomic basis for RNA alterations in cancer
Claudia Calabrese et al.
NATURE (2020)
Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified
Sehui Kim et al.
VIRCHOWS ARCHIV (2020)
STAT3 Mutation Is Associated with STAT3 Activation in CD30+ ALK- ALCL
Emma I. Andersson et al.
CANCERS (2020)
Peripheral T cell lymphomas: from the bench to the clinic
Danilo Fiore et al.
NATURE REVIEWS CANCER (2020)
Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib
Dylan Graetz et al.
HAEMATOLOGICA (2019)
Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation
Rong Jia et al.
RNA (2019)
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability-High Cases in 67,000 Patient Samples
Sally E. Trabucco et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study
Guilin Tang et al.
MODERN PATHOLOGY (2019)
Association of JAK2-V617F Mutations Detected by Solid Tumor Sequencing With Coexistent Myeloproliferative Neoplasms
Gregory Riedlinger et al.
JAMA ONCOLOGY (2019)
EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer
Chun-Chia Cheng et al.
LUNG CANCER (2018)
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
Qingsong Gao et al.
CELL REPORTS (2018)
A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal
James X. Sun et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors
Ryan N. Ptashkin et al.
JAMA ONCOLOGY (2018)
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Tammy Linlin Song et al.
BLOOD (2018)
TFG-MET fusion in an infantile spindle cell sarcoma with neural features
Uta Flucke et al.
GENES CHROMOSOMES & CANCER (2017)
PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
V. Atsaves et al.
LEUKEMIA (2017)
Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations
Jing Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions
C. A. van der Weyden et al.
BLOOD CANCER JOURNAL (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Somatic JAK2 mutations and their tumor phenotypes
Ayalew Tefferi
BLOOD (2016)
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
Jie He et al.
BLOOD (2016)
Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma
Rebecca L. Boddicker et al.
BLOOD (2016)
Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement
Cristina R. Antonescu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Ramona Crescenzo et al.
CANCER CELL (2015)
Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
Rebecca L. King et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R. Parrilla Castellar et al.
BLOOD (2014)
Anchored multiplex FOR for targeted next-generation sequencing
Zongli Zheng et al.
NATURE MEDICINE (2014)
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma
Michela Boi et al.
BLOOD (2013)
CD30 expression in peripheral T-cell lymphomas
Elena Sabattini et al.
HAEMATOLOGICA (2013)
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features
Bettina Bisig et al.
HAEMATOLOGICA (2013)
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton et al.
NATURE BIOTECHNOLOGY (2013)
t(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5
Stefan Ehrentraut et al.
PLOS ONE (2013)
Janus Kinase Deregulation in Leukemia and Lymphoma
Edwin Chen et al.
IMMUNITY (2012)
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
Andrew L. Feldman et al.
BLOOD (2011)
PCM1-JAK2-fusion: a potential treatment target in myelodysplastic-myeloproliferative and other hemato-lymphoid neoplasms
Sylvia Hoeller et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
A. L. Feldman et al.
LEUKEMIA (2009)
ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified:: report from the International Peripheral T-Cell Lymphoma Project
Kerry J. Savage et al.
BLOOD (2008)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The Frequency of Immunoglobulin Heavy Chain Gene and T-Cell Receptor γ-Chain Gene Rearrangements and Epstein-Barr Virus in ALK+ and ALK- Anaplastic Large Cell Lymphoma and Other Peripheral T-Cell Lymphomas
Brent T. Tan et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma
J Adélaïde et al.
LEUKEMIA (2006)
PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation
A Murati et al.
LEUKEMIA (2005)
Peripheral T-cell lymphomas expressing CD30 and CD15
TS Barry et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Share Paper
